deleobuvir
Jump to navigation
Jump to search
Indications
- treatment of hepatitis C virus
- for use with faldaprevir & ribavirin
Dosage
- 600 mg BID
Mechanism of action
- nonnucleoside polymerase inhibitor
More general terms
References
- ↑ Zeuzem S et al. Faldaprevir and deleobuvir for HCV genotype 1 infection. N Engl J Med 2013 Aug 15; 369:630 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23944300 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1213557